RXRX

Recursion Pharmaceuticals Inc

research_scan theme='biotech-genomics'; value_chain_position='picks-and-shovels'; Phenomic platform (Phenom imaging at ~2.2M images/week per 2025 disclosure, inferring) plus post-Exscientia merger compute footprint; partnerships with Roche/Genentech, Bayer, Sanofi. Revenue model partnership-shaped (milestones + low-single-digit royalties), not subscription-shaped — the negative test of the AI-DD 'durable platform pricing' counter-narrative to C-04.